TickerFactsScreenerDevelopers

ABVC BIOPHARMA, INC. (ABVC) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$1.05M2011: -$1.59M2012: -$915.1K2013: -$37.8K2014: $1.2K2015: $3.4K2016: -$3.47M2017: -$1.49M2018: -$900.5K2019: -$3.13M2020: -$4.56M2021: -$7.60M2022: -$7.40M2023: -$4.19M2024: -$1.81M2025: -$2.99M-$2.99M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$2.99M-65.1%
2024-$1.81M+56.8%
2023-$4.19M+43.4%
2022-$7.40M+2.6%
2021-$7.60M-66.5%
2020-$4.56M-45.6%
2019-$3.13M-248.1%
2018-$900.5K+39.4%
2017-$1.49M+57.3%
2016-$3.47M-103513.9%
2015$3.4K+187.7%
2014$1.2K+103.1%
2013-$37.8K+95.9%
2012-$915.1K+42.6%
2011-$1.59M-52.1%
2010-$1.05M—